TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: <0.300nMAssay Description:Binding affinity to VEGFR3 (unknown origin)More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 8nMAssay Description:ATP competitive inhibition of human Flt4More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 17nMAssay Description:Binding affinity to VEGFR3 (unknown origin)More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 1.09E+3nMAssay Description:Inhibition of VEGFR3More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 1.09E+3nMAssay Description:Inhibition of VEGFR3More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: >2.00E+3nMAssay Description:Inhibition of FLT4 (unknown origin)More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: >2.00E+3nMAssay Description:Inhibition of FLT4 (unknown origin)More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: 9.39E+3nMAssay Description:Inhibition of VEGFR3More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: >1.00E+6nMAssay Description:Inhibition of VEGFR3More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: >1.00E+6nMAssay Description:Inhibition of VEGFR3More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataKi: >1.00E+6nMAssay Description:Inhibition of VEGFR3More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:Inhibition of VEGFR3 (unknown origin)More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:Inhibition of VEGFR3 (unknown origin)More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:Inhibition of VEGFR3 (unknown origin)More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.110nMAssay Description:Inhibition of VEGFR3 (unknown origin)More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of VEGFR3 phosphorylation by cell based assayMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.240nMAssay Description:Inhibition of VEGFR3More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of VEGFR3 phosphorylation by cell based assayMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibition of human recombinant VEGFR3 in cell free system after 90 minsMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.700nMAssay Description:Inhibition of human FLT4 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.730nMAssay Description:Inhibition of human VEGFR3 using poly[Glu:Tyr] (4:1) substrate and [gamma-33P]-ATP by radiometric biochemical kinase assayMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.800nMAssay Description:Inhibition of VEGFR3More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.900nMAssay Description:Inhibition of FLT4 (unknown origin) incubated for 1 hr by spectrophotometric analysisMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 1nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibition of FLT4 (unknown origin)More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 1.10nMAssay Description:Inhibition of VEGFR3More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 1.10nMAssay Description:Inhibition of human VEGFR3 using poly[Glu:Tyr] (4:1) substrate and [gamma-33P]-ATP by radiometric biochemical kinase assayMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 1.10nMAssay Description:Inhibition of VEGFR3 (unknown origin) by AlphaScreen assayMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 1.10nMAssay Description:Inhibition of human FLT4 using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP by scintillation counting methodMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 1.20nMAssay Description:Inhibition of human VEGFR3 using poly[Glu:Tyr] (4:1) substrate and [gamma-33P]-ATP by radiometric biochemical kinase assayMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Mus musculus (mouse))
National Research Centre
Curated by ChEMBL
National Research Centre
Curated by ChEMBL
Affinity DataIC50: 1.5nMAssay Description:Inhibition of mouse VEGFR-3 (818 to 1363 residues)More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 1.70nMAssay Description:Inhibition of Flt4 (unknown origin)More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 1.80nMAssay Description:Inhibition of Flt4 (unknown origin) after 20 mins by scintillation countingMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 2nMT: 2°CAssay Description:Activity of VEGFR-3 is measured by ELISA assay by measuring the intensity of phosphorylation of the substrate poly Glu-Tyr.More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 2nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 2.30nMAssay Description:Inhibition of VEGFR3 (unknown origin)More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 2.60nMAssay Description:Inhibition of human VEGFR3 using poly[Glu:Tyr] by Hotspot assayMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 2.70nMAssay Description:Inhibition of human FLT4 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 2.80nMAssay Description:Inhibition of FLT4 (unknown origin) preincubated for 60 mins followed by biotinylated-poly (Glu, Tyr) 4:1 substrate addition measured after 1 hr by A...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 2.80nMAssay Description:Inhibition of Flt-4 (unknown origin) using poly(Glu, Tyr) 4:1 as substrate preincubated for 60 mins followed by substrate addition measured after 1 h...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 2.80nMAssay Description:Inhibition of VEGFR3More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibition of human VEGFR3More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
TargetVascular endothelial growth factor receptor 3(Homo sapiens (Human))
Qilu Pharmaceutical
Curated by ChEMBL
Qilu Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 3nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair